SNZZF Stock, Senzime AB Information

Senzime AB develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during, and after surgery. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Its product includes TetraGraph and TetraSens. Its geographical segments include Sweden, United States, Europe/Oceania, and Asia.